Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

Novartis building

Novartis’ Exjade gets EU approval for thalassaemia

First oral treatment for condition characterised by red blood cell problems and anaemia

- PMLiVE

FDA clears six new drugs in time for the new year

Brings 2012 tally to 39 – the highest for more than 15 years

- PMLiVE

Sarah Bater joins Celgene

Will head human resources in UK and Ireland

- PMLiVE

Get connected in pharma marketing

Marketers who are using new media to provide value and relevance are driving value in their brands and will change the way healthcare is delivered

- PMLiVE

Merck drops plans to file Tredaptive in US

Pharma company also says cardiovascular drug should not be prescribed to new patients in Europe

- PMLiVE

Lilly pays $29m to settle foreign bribery charges

US Securities and Exchange Commission charges centre on activities in Russia, China, Brazil and Poland

- PMLiVE

Pharma ‘influencing Polish drug market’

Leads to recommendations for expensive and ineffective medicines says study

- PMLiVE

Hanspeter Spek to retire from Sanofi

President of global operations will step down after 18 years at the pharma company

- PMLiVE

Sanofi boosts animal health business with Dosch acquisition

Opens door to €350m market for company’s Merial division

- PMLiVE

New EC anti-smoking plans include ban on flavoured tobacco

Pictorial health warnings on cigarettes and regulation for e-cigarettes also proposed

- PMLiVE

Lundbeck slumps as it cuts sales, profit guidance

Comes despite three new products due to hit market

- PMLiVE

Vertex reports fatal reactions with hepatitis C drug

Adds boxed warning to Incivek

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links